Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,770
Closed -$435K 62
2023
Q2
$435K Buy
3,770
+8
+0.2% +$908 0.14% 44
2023
Q1
$400K Buy
3,762
+8
+0.2% +$864 0.13% 50
2022
Q4
$416K Sell
3,754
-25
-0.7% -$2.56K 0.15% 46
2022
Q3
$325K Buy
3,779
+8
+0.2% +$714 0.12% 56
2022
Q2
$344K Buy
3,771
+10
+0.3% +$887 0.12% 55
2022
Q1
$309K Sell
3,761
-101
-3% -$7.96K 0.1% 62
2021
Q4
$296K Buy
3,862
+506
+15% +$40.3K 0.09% 64
2021
Q3
$252K Sell
3,356
-22
-0.7% -$1.67K 0.08% 68
2021
Q2
$263K Sell
3,378
-731
-18% -$54.4K 0.08% 68
2021
Q1
$302K Buy
4,109
+64
+2% +$4.72K 0.1% 58
2020
Q4
$316K Buy
4,045
+508
+14% +$38.9K 0.14% 51
2020
Q3
$280K Buy
3,537
+117
+3% +$9.16K 0.14% 48
2020
Q2
$252K Buy
3,420
+5
+0.1% +$376 0.14% 48
2020
Q1
$251K Buy
3,415
+5
+0.1% +$393 0.18% 49
2019
Q4
$296K Sell
3,410
-55
-2% -$4.52K 0.2% 45
2019
Q3
$278K Buy
3,465
+3
+0.1% +$240 0.21% 43
2019
Q2
$277K Sell
3,462
-730
-17% -$55.9K 0.21% 42
2019
Q1
$333K Buy
+4,192
New +$314K 0.24% 41

Other funds holding MRK

Corrigan Financial's MRK Position: Q3 2023 in Review

Corrigan Financial sold out of Merck (MRK) in Q3 2023, closing a stake of 3,770 shares — an estimated $435K sold.

Corrigan Financial first reported a position in MRK in Q1 2019 and held it in 18 quarters. The position peaked at $435K in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Corrigan Financial reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Corrigan Financial sold 3,770 Merck shares in Q3 2023, an estimated $435K.
  • Corrigan Financial first reported a position in Merck in Q1 2019 and held it in 18 quarters.
  • Corrigan Financial's Merck position peaked at $435K in Q2 2023.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Corrigan Financial's 13F filing for Q3 2023, filed 16 Oct 2023.